These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Severe liver damage on terbinafine. Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985370 [No Abstract] [Full Text] [Related]
43. Pharmacokinetics and pharmacology of terbinafine and itraconazole. Leyden J J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S42-7. PubMed ID: 9594936 [TBL] [Abstract][Full Text] [Related]
44. The efficacy and safety of terbinafine in children. Gupta AK; Adamiak A; Cooper EA J Eur Acad Dermatol Venereol; 2003 Nov; 17(6):627-40. PubMed ID: 14761128 [TBL] [Abstract][Full Text] [Related]
45. Acute generalized exanthematous pustulosis induced by terbinafine in a child confirmed by patch testing. Zaouak A; Ben Salem F; Charfi O; Hammami H; Fenniche S Int J Dermatol; 2019 Feb; 58(2):e42-e43. PubMed ID: 30255495 [No Abstract] [Full Text] [Related]
47. Terbinafine for dermatophytes in skin and nail. Drug Ther Bull; 1992 Jun; 30(12):47-8. PubMed ID: 1623815 [No Abstract] [Full Text] [Related]
48. Clinical efficacy and tolerability of terbinafine (Lamisil)--a new topical and systemic fungicidal drug for treatment of dermatomycoses. Villars V; Jones TC Clin Exp Dermatol; 1989 Mar; 14(2):124-7. PubMed ID: 2689015 [TBL] [Abstract][Full Text] [Related]
49. Acute generalized exanthematous pustulosis due to terbinafine. Ross CL; Shevchenko A; Mollanazar NK; Hsu S; Motaparthi K Dermatol Ther; 2018 Jul; 31(4):e12617. PubMed ID: 29786933 [TBL] [Abstract][Full Text] [Related]
50. Use of terbinafine in rare and refractory mycoses. Revankar SG; Nailor MD; Sobel JD Future Microbiol; 2008 Feb; 3(1):9-17. PubMed ID: 18230029 [TBL] [Abstract][Full Text] [Related]
51. [Terbinafine and cholestatic hepatitis]. Tejada García M; Llvona Hevia AM; Martín Arias L; García-Pando AC Med Clin (Barc); 1997 Sep; 109(9):356. PubMed ID: 9379769 [No Abstract] [Full Text] [Related]
52. [Acute hepatitis related to the ingestion of terbinafine]. Vantaux P; Grasset D; Nougue J; Lagier E; Seigneuric C Gastroenterol Clin Biol; 1996; 20(4):402-3. PubMed ID: 8758509 [No Abstract] [Full Text] [Related]
53. Two cases of annular acute generalized exanthematous pustulosis induced by terbinafine. Olivier S; De Montjoye L; Tromme I; Baeck M Eur J Dermatol; 2018 Apr; 28(2):236-238. PubMed ID: 29336314 [No Abstract] [Full Text] [Related]
54. Symmetrical drug-related intertriginous and flexural erythema (Baboon syndrome) induced by simultaneous exposure to oral and topical terbinafine. Bhari N; Sahni K; Dev T; Sharma VK Int J Dermatol; 2017 Aug; 56(8):e168-e170. PubMed ID: 28244137 [No Abstract] [Full Text] [Related]
55. Dermatomycoses in the Israeli defense forces-Epidemiological and clinical aspects. Ravid A; Michael F; Daniel C; Esther S Mycoses; 2020 Jan; 63(1):65-70. PubMed ID: 31599024 [TBL] [Abstract][Full Text] [Related]
56. Itraconazole, terbinafine possibly linked to liver failure. Am J Health Syst Pharm; 2001 Jun; 58(12):1076. PubMed ID: 11449844 [No Abstract] [Full Text] [Related]
57. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. Gupta AK; Lynde CW; Lauzon GJ; Mehlmauer MA; Braddock SW; Miller CA; Del Rosso JQ; Shear NH Br J Dermatol; 1998 Mar; 138(3):529-32. PubMed ID: 9580815 [TBL] [Abstract][Full Text] [Related]